American Association for Cancer Research (AACR), 2023.
سنة النشر:
2023
الوصف:
Table S1. Deregulated proteins between JAK2(+) PV and JAK2(-) ET/PMF. Table S2. Deregulated proteins between JAK2(+) ET and JAK2(-) ET/PMF. Table S3. Deregulated proteins between JAK2(+) PMF and JAK2(-) ET/PMF. Table S4. Deregulated proteins between JAK2(+) PV and JAK2(+) PMF. Table S5. Deregulated proteins between JAK2(+) ET and JAK2(+) PMF. Table S6. Deregulated proteins between JAK2(+) PV and JAK2(+) ET. Table S7. Deregulated pathways between JAK2(+) PV and JAK2(-) ET/PMF. Table S8. Deregulated pathways between JAK2(+) ET and JAK2(-) ET/PMF. Table S9. Deregulated pathways between JAK2(+) PMF and JAK2(-) ET/PMF. Table S10. Deregulated pathways between JAK2(+) PV and JAK2(+) PMF. Table S11. Deregulated pathways between JAK2(+) ET and JAK2(+) PMF. Table S12. Deregulated pathways between JAK2(+) PV and JAK2(+) ET.